The induction of cytolytic anti-tumor immunity relies on type-1 T cell responses [conducted by interferon (IFN)-γ- and IL-2-producing T cells (73)], as opposed to type-2 T cell responses (defined by T cells producing IL-4, IL-6, and IL-10) leading to cytolytic activity suppression (74). Here, IFNG is linked to neoplasm.